QuidelOrtho CorporationQDELNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank77
5Y CAGR-11.3%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-11.3%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.36% |
| Q3 2025 | -9.19% |
| Q2 2025 | -14.10% |
| Q1 2025 | 12.47% |
| Q4 2024 | -15.38% |
| Q3 2024 | -0.71% |
| Q2 2024 | -4.90% |
| Q1 2024 | -0.17% |
| Q4 2023 | -3.58% |
| Q4 2023 | -1.44% |
| Q3 2023 | 0.16% |
| Q2 2023 | -3.11% |
| Q1 2023 | -1.98% |
| Q4 2022 | 91.81% |
| Q3 2022 | 29.55% |
| Q1 2022 | 1.12% |
| Q4 2021 | 10.16% |
| Q3 2021 | 4.87% |
| Q2 2021 | -3.02% |
| Q1 2021 | -8.59% |
| Q4 2020 | 18.87% |
| Q3 2020 | 2.28% |
| Q2 2020 | 28.03% |
| Q1 2020 | 9.75% |
| Q4 2019 | 24.62% |
| Q3 2019 | 2.16% |
| Q2 2019 | -15.84% |
| Q1 2019 | 10.20% |
| Q4 2018 | -3.53% |
| Q3 2018 | -1.36% |
| Q2 2018 | 5.25% |
| Q1 2018 | 18.24% |
| Q4 2017 | 42.93% |
| Q3 2017 | -2.08% |
| Q2 2017 | -3.15% |
| Q1 2017 | 4.89% |
| Q4 2016 | -14.69% |
| Q3 2016 | -8.85% |
| Q2 2016 | -24.01% |
| Q1 2016 | 27.85% |